dr. bekaii-saab discusses the next steps with regorafenib in crc
Published 6 years ago • 69 plays • Length 0:57Download video MP4
Download video MP3
Similar videos
-
1:39
dr. bekaii-saab on dosing strategies with regorafenib in crc
-
2:26
dr. bekaii-saab on the impact of regorafenib in crc
-
1:20
dr. bekaii-saab on the use of regorafenib in patients with mcrc
-
1:21
dr. bekaii-saab discusses regorafenib use in mcrc
-
2:04
dr. bekaii saab on the role of immunotherapy in crc
-
9:04
regorafenib - stivarga ®
-
3:52
brief history of probiotics
-
10:18
obesity and risk of cancer
-
5:31
practical advice for using regorafenib
-
1:16
dr. bekaii-saab on tas-102 and regorafenib in mcrc
-
0:20
copy of dr. bekaii-saab on tas-102 and regorafenib in mcrc
-
2:27
dr. bekaii-saab on the redos study in metastatic colorectal cancer
-
1:21
dr. george demetri explains the side effects associated with regorafenib
-
1:23
dr. bekaii-saab on benefits associated with regorafenib or tas-102 for crc
-
1:33
dr. bekaii saab on the expansion of treatment options in colorectal cancer
-
3:53
regorafenib in colorectal cancer: optimizing the dose
-
8:18
the optimal dosing strategy for regorafenib in mcrc
-
0:46
copy of dr. bekaii-saab discusses regorafenib use in mcrc
-
4:14
the use of regorafenib in clinical practice
-
1:50
dr. bekaii-saab on sequencing regorafenib and tas-102 in crc
-
1:21
dr. bekaii-saab on expanding landscape in crc
-
4:28
proactive side effect management with regorafenib